Revvity Acquires ACD/Labs to Expand Revvity Signals Scientific Software Capabilities
November 10, 2025
Revvity, Inc. has entered into a definitive agreement to acquire ACD/Labs, a provider of scientific software for analytical characterization and molecular design. The deal is expected to close in late Q4 2025 and will expand Revvity Signals by unifying analytical data with actionable scientific insights across the end-to-end scientific workflow.
- Buyers
- Revvity, Inc.
- Targets
- ACD/Labs
- Industry
- Cloud & SaaS
- Location
- Canada
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Revvity to Acquire Human Cell Design to Expand Metabolic and GLP-1 Drug Discovery Tools
September 11, 2026
Biotechnology
Revvity entered into a definitive agreement to acquire Human Cell Design (HCD), a France-based biotechnology company focused on human pancreatic beta cell models and preclinical research solutions for diabetes, obesity, and other metabolic diseases. The acquisition is expected to strengthen Revvity’s life sciences tools for drug discovery, screening, and preclinical research, including next-generation GLP-1 and other metabolic therapies.
-
ATS Corporation Acquires Avidity Science
September 22, 2023
Medical Devices
ATS Corporation has entered into a definitive agreement to acquire Avidity Science, a designer and manufacturer of automated water purification and delivery systems for biomedical and life science applications, for US$195 million. The acquisition strengthens ATS's life sciences capabilities and is expected to close in Q4 2023 subject to customary regulatory filings.
-
Studio Science Acquires RevTech360
March 22, 2023
IT Services
Studio Science, a design and innovation consultancy backed by Inoca Capital Partners, has acquired RevTech360, a MuleSoft- and Salesforce-focused digital transformation and CRM consulting firm based in Indianapolis. The acquisition bolsters Studio Science’s Salesforce Commerce Cloud and cross-cloud integration capabilities and adds certified architects and developers to its enterprise offerings.
-
Avidity Science Acquires Lab Products, Bio Medic Data Systems, Hydropac and Harford Systems
October 26, 2020
Medical Devices
Avidity Science, a ShoreView portfolio company, has acquired Lab Products, Inc. and its divisions — Bio Medic Data Systems, Hydropac and Harford Systems — expanding its portfolio of water purification and delivery products, control and monitoring solutions, and vivarium equipment for biomedical research. The transaction is the fifth add-on completed under ShoreView's ownership and is intended to broaden Avidity's product capabilities and geographic presence in the life-science research market.
-
Flexera Acquires Revulytics
February 5, 2020
Software
Flexera has acquired Revulytics, a Waltham, Massachusetts–based provider of cloud-based software usage analytics and compliance intelligence. The acquisition expands Flexera’s software monetization portfolio by adding usage and compliance analytics capabilities to help software vendors better understand product usage, drive pricing and roadmap decisions, and generate revenue from unlicensed use.
-
Validant Acquires DataRevive
November 1, 2019
Healthcare Services
Validant, a transatlantic quality, compliance and regulatory consulting group backed by GHO Capital, has acquired DataRevive, a regulatory strategy and consulting firm focused on novel therapeutics and biologics. The deal expands Validant's capabilities in life‑science regulatory consulting and adds a Washington, D.C. location to its existing footprint in San Francisco, Research Triangle Park and Cork, Ireland.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.